{"id":"W2582331875","doi":"10.1182/blood.v116.21.2886.2886","title":"Evaluation of CPX-351 (cytarabine:daunorubicin) Liposome Injection Anti-Leukemic Activity Against Primary Patient Leukemia Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Leukemia; Cytarabine; Medicine; Daunorubicin; Myeloid leukemia; Acute lymphocytic leukemia; Chronic lymphocytic leukemia; Bone marrow; Immunology; Myeloid; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000322593,0.0002528052,0.0002640084,0.00020228,0.0001229531,0.000246522,0.0001324338,0.0001970119,0.001405986],"category_scores_gemma":[0.000138806,0.00007717422,0.000136494,0.0001729795,0.0001446949,0.0001202878,0.0001136301,0.0003323523,0.0003279993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000188367,"about_ca_system_score_gemma":0.0001434694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005142192,"about_ca_topic_score_gemma":0.0003884593,"domain_scores_codex":[0.9998513,0.00004517302,0.00001295009,0.00003423955,0.00003193465,0.00002433636],"domain_scores_gemma":[0.9998977,0.00003662407,0.0000149619,0.000009041798,0.00002153753,0.00001997214],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006702567,0.0002305349,0.0004973375,0.00008994629,0.00001288763,0.00007554392,0.00005575164,0.0002649185,0.9938513,0.00006150451,0.00006216746,0.00412782],"study_design_scores_gemma":[0.00007660864,0.005047024,0.003249608,0.000004429362,0.00003343596,0.0003504888,0.00002004302,0.001196401,0.989077,0.00001025329,0.000930898,0.000003716872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957564,0.001031348,0.002030008,0.00002153275,0.00001101892,0.0001346346,0.0002159493,0.00005647617,0.0007424687],"genre_scores_gemma":[0.9964963,0.000556193,0.001716493,0.00001640287,0.000006410218,0.00006221342,0.0003744145,0.000008267165,0.000763426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001405986,"threshold_uncertainty_score":0.004703462,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01776896138947283,"score_gpt":0.2770523405404978,"score_spread":0.259283379151025,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}